Latest News and Press Releases

WASHINGTON, DC, June 14, 2023 (GLOBE NEWSWIRE) -- Up to 50 percent of people in the U.S. with Alzheimer’s receive an imprecise or inaccurate diagnosis of their cognitive condition. The tools...

Washington, D.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Statement by Global Alzheimer’s Platform Foundation® President John Dwyer: “Once again, the Centers for Medicare and Medicaid Services (CMS) has...

WASHINGTON, DC, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today, the Global Alzheimer’s Platform Foundation (GAP) proudly announced the recipients of the 2022 National Citizen Scientist Awards®.  GAP’s...

Washington, D.C., Jan. 06, 2023 (GLOBE NEWSWIRE) -- "We applaud the Food and Drug Administration (FDA)’s decision to grant accelerated approval to lecanemab, a treatment that offers millions of...

WASHINGTON, DC, Nov. 15, 2022 (GLOBE NEWSWIRE) -- In 18 months, the Global Alzheimer’s Platform Foundation (GAP) recruited more than 1,000 participants to enroll in the first-ever head-to-head study...

WASHINGTON, DC, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Today, the Global Alzheimer’s Platform Foundation (GAP) applauds and welcomes the Phase 3 study results on lecanemab for treating Alzheimer’s...

WASHINGTON, DC, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) and WCG announced a joint program today that will increase the availability of educational...

WASHINGTON, DC, July 14, 2022 (GLOBE NEWSWIRE) -- Today, Global Alzheimer's Platform Foundation (GAP) President John Dwyer announced the launch of a new mobile health site, which is hitting the road...